Patent · US Active

Huperzine a compound for treatment of alzheimer's disease

US8097726B2 · kind B2 · utility

0Cited by
9References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 17, 2007
Grant dateJan 17, 2012
Priority date—
Expiry dateJan 30, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D221/22
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

A huperzine A compound is provided. The huperzine A compound has following formula:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.